Cargando…
Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics
The emergence of lethal coronaviruses follows a periodic pattern which suggests a recurring cycle of outbreaks. It remains uncertain as to when the next lethal coronavirus will emerge, though its eventual emergence appears to be inevitable. New mutations in evolving SARS-CoV-2 variants have provided...
Autores principales: | Berkowitz, Reed L., Bluhm, Andrew P., Knox, Glenn W., McCurdy, Christopher R., Ostrov, David A., Norris, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647780/ https://www.ncbi.nlm.nih.gov/pubmed/37958703 http://dx.doi.org/10.3390/ijms242115718 |
Ejemplares similares
-
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells
por: Ostrov, David A., et al.
Publicado: (2021) -
Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain
por: Wilson, Lisa L., et al.
Publicado: (2022) -
Potential independent action of sigma receptor ligands through inhibition of the Kv2.1 channel
por: Liu, Xinying, et al.
Publicado: (2017) -
Retinal Photoreceptor Protection in an AMD-Related Mouse Model by Selective Sigma-1 or Sigma-2 Receptor Modulation
por: Mavlyutov, Timur A., et al.
Publicado: (2022) -
Pharmacology and Therapeutic Potential of Sigma(1) Receptor Ligands
por: Cobos, E.J, et al.
Publicado: (2008)